World's Best Scientists 2026 revealed!
Hematology/Oncology and Stem Cell Therapy
H-index 11

Hematology/Oncology and Stem Cell Therapy

Ranking & Metrics

Discipline name Position Best Scientists Publications D-Index
Medicine 2615 18 21 9

Additional Metrics

Number of Best Scientists*: 27
Documents by Best Scientists*: 28
Top 100 Ranked Scientists*: 0
SCIMAGO H-index: 31
SCIMAGO SJR: 0.554
Impact Factor: N/A

Overview

Top Research Topics at Hematology/Oncology and Stem Cell Therapy?

The journal investigates studies in Internal medicine, Oncology, Pathology, Transplantation and Immunology. Gastroenterology and Surgery are some topics wherein Internal medicine research discussed in it have an impact. The majority of Surgery studies are focused on the issues of Retrospective cohort study.

The research on Oncology featured in it combines topics in other fields like Regimen, Myeloid leukemia, Lymphoma, Breast cancer and Radiation therapy. The study on Myeloid leukemia presented in it intersects with the topics under Leukemia. As a part of it, discussions in Pathology involve topics like Bone marrow, Biopsy and Immunohistochemistry.

The studies on Transplantation discussed can also contribute to research in the domains of Stem cell and Multiple myeloma. Immune system is a major topic of Immunology research presented in Hematology/Oncology and Stem Cell Therapy.

  • Internal medicine (41.64%)
  • Oncology (20.98%)
  • Pathology (17.21%)

What are the most cited papers published in the journal?

  • Natural killer cells: In health and disease (144 citations)
  • The immunoinhibitory B7-H1 molecule as a potential target in cancer: Killing many birds with one stone (73 citations)
  • Cancer care in Jordan (68 citations)

Research areas of the most cited articles at Hematology/Oncology and Stem Cell Therapy:

The published papers investigate areas of study like Internal medicine, Immunology, Cancer, Hematopoietic stem cell transplantation and Transplantation. While the journal articles focused on Internal medicine, they were also able to explore topics like Surgery and Oncology. The journal papers hold forums on Immunology that merge themes from other disciplines such as Hemophagocytic lymphohistiocytosis, Cell and Liver function tests.

What topics the last edition of the journal is best known for?

  • Cancer
  • Internal medicine
  • Disease

The previous edition focused in particular on these issues:

Hematology/Oncology and Stem Cell Therapy is mainly concerned with subjects like Internal medicine, Oncology, Cancer research, Gastroenterology and Chemotherapy. Retrospective cohort study, Myeloid leukemia, Regimen, Hematopoietic stem cell transplantation and Transplantation studies are all carried out as a component of the study in Internal medicine presented. The subject of Disease, which is connected to the field of Immunology, serves as the foundation of the Myeloid leukemia research featured in it.

The work on Transplantation tackled in it brings together disciplines like Complication and Pediatrics. The journal holds forums on Oncology that merges themes from other disciplines such as Cytarabine, Stem cell, Melphalan and Lymphoma. The studies in Gastroenterology featured incorporate elements of Adverse effect and Immune system.

The most cited articles from the last journal are:

  • G6PD deficiency in the COVID-19 pandemic: Ghost within Ghost. (8 citations)
  • Bronchoalveolar lavage-based COVID-19 testing in patients with cancer. (7 citations)
  • Venetoclax and decitabine for treatment of relapsed T-cell acute lymphoblastic leukemia: A case report and review of literature. (6 citations)

Papers citation over time

A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.

The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.

The top authors publishing in Hematology/Oncology and Stem Cell Therapy (based on the number of publications) are:

  • Mahmoud Aljurf (26 papers) published 4 papers at the last edition, 2 less than at the previous edition,
  • Naeem Chaudhri (16 papers) published 2 papers at the last edition the same number as at the previous edition,
  • Shahrukh K. Hashmi (16 papers) published 3 papers at the last edition, 4 less than at the previous edition,
  • Walid Rasheed (16 papers) published 1 paper at the last edition, 3 less than at the previous edition,
  • Mohamed Amine Bekadja (12 papers) published 2 papers at the last edition.

The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.

Only papers with recognized affiliations are considered

The top affiliations publishing in Hematology/Oncology and Stem Cell Therapy (based on the number of publications) are:

  • King Hussein Cancer Center (31 papers) published 2 papers at the last edition, 4 less than at the previous edition,
  • Mayo Clinic (23 papers) published 10 papers at the last edition, 6 more than at the previous edition,
  • American University of Beirut (21 papers) published 1 paper at the last edition, 1 less than at the previous edition,
  • Tehran University of Medical Sciences (17 papers) published 3 papers at the last edition the same number as at the previous edition,
  • Alfaisal University (15 papers) absent at the last edition.

The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.

Publication chance based on affiliation

The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.

The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.

During the most recent 2021 edition, 9.09% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 25.71% were posted by at least one author from the top 10 institutions publishing in the journal. Another 7.14% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 11.43% of all publications and 55.71% were from other institutions.

Returning Authors Index

A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.

The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.

Returning Institution Index

The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.

The experience to innovation index

Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).

The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:

  • Novice - P < 5 or C < 25 (the number of publications less than 5 or the number of citations less than 25),
  • Competent - P < 10 or C < 100 (the number of publications less than 10 or the number of citations less than 100),
  • Experienced - P < 25 or C < 625 (the number of publications less than 25 or the number of citations less than 625),
  • Master - P < 50 or C < 2500 (the number of publications less than 50 or the number of citations less than 2500),
  • Star - P ≥ 50 and C ≥ 2500 (both the number of publications greater than 50 and the number of citations greater than 2500).

The chart below illustrates experience levels of first authors in cases of publications with multiple authors.

Educational Pathway in Hematology/Oncology and Stem Cell Therapy

When discussing hematology, oncology, and stem cell therapy, it's important to remember the many healthcare professionals who dedicate their lives to these specialized fields. Nursing professionals, in particular, play an integral role in patient recovery and treatment processes. If you are considering a career in this field, you might want to know how to become a nurse specializing in hematology, oncology, and stem cell therapy. To become a nurse in these specialized areas, you'll need to first become a registered nurse by completing a nursing program and passing your national licensing examination. Then, it may also be beneficial to pursue additional medical training focused on internal medicine, oncology, stem cell therapies, and related fields. You can further your career by becoming a certified pediatric hematology oncology nurse, a role that requires knowledge in various areas such as Myeloid leukemia, Lymphoma, Breast cancer, and Radiation therapy unfortunately, this certification is currently only available in certain regions, like Washington. In fact, we have compiled a comprehensive guide on how to become a nurse in washington which might be applicable and useful even for those residing in different areas. The guide leads you through every step of pursuing a career in nursing, right from enrolling in nursing programs, to passing your licensing examination, and even becoming specialized in fields like hematology and oncology. Ultimately, having specialized nurses with knowledge in hematology, oncology, and stem cell therapy can be beneficial to both the patients and the research community. They are not only able to supervise treatment regimens and ensure patient comfort, but they also contribute to research, helping uncover new treatment methods and insights in these fields.

Top Publications

  • Genotypic and Phenotypic Characteristics of Acute Promyelocytic Leukemia Translocation Variants.

    Abdul Mannan;Ibrahim N. Muhsen;Eva Barragán;Miguel A. Sanz

    (2020)
    39 Citations
  • Alternative donor hematopoietic stem cell transplantation for sickle cell disease in Europe.

    Eliane Gluckman;Barbara Cappelli;Graziana Maria Scigliuolo;Josu De la Fuente

    (2020)
    26 Citations
  • Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic cell transplantation program (Part I): Minimum requirements and beyond.

    (2020)
    26 Citations
  • Worldwide Network for Blood and Marrow Transplantation (WBMT) recommendations for establishing a hematopoietic stem cell transplantation program in countries with limited resources (Part II): Clinical, technical and socio-economic considerations

    (2020)
    25 Citations
  • Special report: Summary of the first meeting of African Blood and Marrow Transplantation (AfBMT) group, Casablanca, Morocco, April 19-21, 2018 held under the auspices of the Worldwide Network for Blood and Marrow Transplantation (WBMT).

    Mhamed Harif;Daniel Weisdorf;Nicolas Novitzky;Jeff Szer

    (2020)
    18 Citations
  • Comparative effectiveness of busulfan/cyclophosphamide versus busulfan/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome.

    (2020)
    17 Citations
  • Clinical predictors of delayed engraftment in autologous hematopoietic cell transplant recipients

    Forat Lutfi;William Paul Skelton;Yu Wang;Emma Rosenau

    (2020)
    13 Citations
  • Survival following relapse after allogeneic hematopoietic cell transplantation for acute leukemia and myelodysplastic syndromes in the contemporary era.

    (2020)
    12 Citations
  • Strategic priorities for hematopoietic stem cell transplantation in the EMRO region

    Syed Osman Ahmed;Riad El Fakih;Alaa Elhaddad;Amir Ali Hamidieh

    (2021)
    10 Citations
  • Synchronous multiple myeloma and Gaucher disease.

    Jorge Monge;Amy Chadburn;Usama Gergis

    (2020)
    7 Citations

Related Online Degrees & Career Pathways

For students exploring Medicine in the USA, it’s valuable to consider related career paths that complement or offer alternative routes within healthcare. One such field is medical coding, where professionals translate healthcare diagnoses and procedures into standardized codes. Understanding the medical coder salary can help gauge the financial viability of this career.

Medical billing and coding remain in demand as healthcare systems evolve, making the medical billing and coding job outlook promising for many graduates. These roles offer flexibility and often can be pursued online, balancing work and study effectively.

Another related avenue is health information management, which focuses on organizing and managing patient data. Students interested in this path can explore some of the most affordable health information management online programs that provide essential skills in healthcare data administration.

Additionally, an online master's degree in nutrition opens doors to careers in dietetics, wellness, and preventive medicine. Nutrition plays a crucial role in patient health, making it a valuable complementary field for those pursuing medical professions.

Best Scientists Contributing to This Journal

Recently Published Articles